101 related articles for article (PubMed ID: 11879736)
1. Preparation and in vitro evaluation of solid dispersions of halofantrine.
Abdul-Fattah AM; Bhargava HN
Int J Pharm; 2002 Mar; 235(1-2):17-33. PubMed ID: 11879736
[TBL] [Abstract][Full Text] [Related]
2. The formulation of Halofantrine as either non-solubilizing PEG 6000 or solubilizing lipid based solid dispersions: physical stability and absolute bioavailability assessment.
Khoo SM; Porter CJ; Charman WN
Int J Pharm; 2000 Sep; 205(1-2):65-78. PubMed ID: 11000543
[TBL] [Abstract][Full Text] [Related]
3. Effects of Polymer/Surfactant as Carriers on the Solubility and Dissolution of Fenofibrate Solid Dispersion.
Yang B; Wu L; Ke J; Zhou L; Chen M; Li S; Feng X
AAPS PharmSciTech; 2019 Feb; 20(3):102. PubMed ID: 30723877
[TBL] [Abstract][Full Text] [Related]
4. Salt formation in solid dispersions consisting of polyacrylic acid as a carrier and three basic model compounds resulting in very high glass transition temperatures and constant dissolution properties upon storage.
Weuts I; Kempen D; Verreck G; Peeters J; Brewster M; Blaton N; Van den Mooter G
Eur J Pharm Sci; 2005; 25(4-5):387-93. PubMed ID: 15894472
[TBL] [Abstract][Full Text] [Related]
5. Anomalous dissolution behavior of celecoxib in PVP/Isomalt solid dispersions prepared using spray drier.
Ghanavati R; Taheri A; Homayouni A
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():501-511. PubMed ID: 28024614
[TBL] [Abstract][Full Text] [Related]
6. Caffeine and nicotinamide enhances the aqueous solubility of the antimalarial agent halofantrine.
Lim LY; Go ML
Eur J Pharm Sci; 2000 Mar; 10(1):17-28. PubMed ID: 10699380
[TBL] [Abstract][Full Text] [Related]
7. A physicochemical basis for the extensive intestinal lymphatic transport of a poorly lipid soluble antimalarial, halofantrine hydrochloride, after postprandial administration to dogs.
Khoo SM; Prankerd RJ; Edwards GA; Porter CJ; Charman WN
J Pharm Sci; 2002 Mar; 91(3):647-59. PubMed ID: 11920750
[TBL] [Abstract][Full Text] [Related]
8. Physical Characterization of Halofantrine-Encapsulated Fat Nanoemulsions.
Haidar I; Harding IH; Bowater IC; McDowall AW
J Pharm Sci; 2019 Jun; 108(6):2153-2161. PubMed ID: 30703385
[TBL] [Abstract][Full Text] [Related]
9. Preparation, characterization and tableting of cilnidipine solid dispersions.
Hu L; Song W; Niu F; Jiao K; Jia Z
Pak J Pharm Sci; 2013 May; 26(3):629-36. PubMed ID: 23625441
[TBL] [Abstract][Full Text] [Related]
10. Enhanced solubility of piperine using hydrophilic carrier-based potent solid dispersion systems.
Thenmozhi K; Yoo YJ
Drug Dev Ind Pharm; 2017 Sep; 43(9):1501-1509. PubMed ID: 28425323
[TBL] [Abstract][Full Text] [Related]
11. Physical properties and solubility studies of Nifedipine-PEG 1450/HPMCAS-HF solid dispersions.
Haware RV; Vinjamuri BP; Gavireddi M; Dave VS; Gupta D; Chougule MB; Stagner WC
Pharm Dev Technol; 2019 Jun; 24(5):550-559. PubMed ID: 30175691
[TBL] [Abstract][Full Text] [Related]
12. A physicochemical basis for the effect of food on the absolute oral bioavailability of halofantrine.
Humberstone AJ; Porter CJ; Charman WN
J Pharm Sci; 1996 May; 85(5):525-9. PubMed ID: 8742945
[TBL] [Abstract][Full Text] [Related]
13. Dissolution properties and characterization of halofantrine-2-hydroxypropyl-beta-cyclodextrin binary systems.
Onyeji CO; Omoruyi SI; Oladimeji FA
Pharmazie; 2007 Nov; 62(11):858-63. PubMed ID: 18065103
[TBL] [Abstract][Full Text] [Related]
14. Development of hot melt co-formulated antimalarial solid dispersion system in fixed dose form (ARLUMELT): Evaluating amorphous state and in vivo performance.
Fule R; Dhamecha D; Maniruzzaman M; Khale A; Amin P
Int J Pharm; 2015 Dec; 496(1):137-56. PubMed ID: 26471056
[TBL] [Abstract][Full Text] [Related]
15. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L
Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445
[TBL] [Abstract][Full Text] [Related]
16. To enhance dissolution rate of poorly water-soluble drugs: glucosamine hydrochloride as a potential carrier in solid dispersion formulations.
Al-Hamidi H; Edwards AA; Mohammad MA; Nokhodchi A
Colloids Surf B Biointerfaces; 2010 Mar; 76(1):170-8. PubMed ID: 19945828
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of gliclazide-polyethylene glycol 4000 solid dispersions.
Patil MP; Gaikwad NJ
Acta Pharm; 2009 Mar; 59(1):57-65. PubMed ID: 19304558
[TBL] [Abstract][Full Text] [Related]
18. Preparation and evaluation of Ibuprofen solid dispersion systems with kollidon particles using a pulse combustion dryer system.
Xu L; Li SM; Sunada H
Chem Pharm Bull (Tokyo); 2007 Nov; 55(11):1545-50. PubMed ID: 17978509
[TBL] [Abstract][Full Text] [Related]
19. Acyclovir-Polyethylene Glycol 6000 Binary Dispersions: Mechanistic Insights.
Venkateskumar K; Parasuraman S; Gunasunderi R; Sureshkumar K; Nayak MM; Shah SAA; Khoo K; Kai HW
AAPS PharmSciTech; 2017 Aug; 18(6):2085-2094. PubMed ID: 28004342
[TBL] [Abstract][Full Text] [Related]
20. Preparation, characterization and in vitro evaluation of tablets containing microwave-assisted solid dispersions of apremilast.
Madan JR; Pawar AR; Patil RB; Awasthi R; Dua K
Polim Med; 2018; 48(1):17-24. PubMed ID: 30657654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]